Hepatocellular cancer: The impact of obesity, type 2 diabetes and a multidisciplinary team

作者: Jessica Dyson , Bryan Jaques , Dipankar Chattopadyhay , Rajiv Lochan , Janine Graham

DOI: 10.1016/J.JHEP.2013.08.011

关键词: Viral hepatitisAutoimmune hepatitisHepatitis CInternal medicineFatty liverHepatitis BPathologyAlcoholic liver diseaseMedicineDiseaseChronic liver disease

摘要: Background & Aims Hepatocellular cancer (HCC) commonly complicates chronic liver disease and increases in incidence have been reported despite falling prevalences of viral …

参考文章(25)
Alicja Wolk, Gloria Gridley, Malin Svensson, Olof Nyrén, Joseph K. McLaughlin, Joseph F. Fraumeni, Hans-Olov Adami, A prospective study of obesity and cancer risk (Sweden). Cancer Causes & Control. ,vol. 12, pp. 13- 21 ,(2001) , 10.1023/A:1008995217664
Steven Allender, Mike Rayner, Asha Kaur, Peter Scarborough, Vito Peto, Coronary heart disease statistics. British Heart Foundation & Stroke Association. ,(2008)
Josep M Llovet, Sergio Ricci, Vincenzo Mazzaferro, Philip Hilgard, Edward Gane, Jean-Frédéric Blanc, Andre Cosme De Oliveira, Armando Santoro, Jean-Luc Raoul, Alejandro Forner, Myron Schwartz, Camillo Porta, Stefan Zeuzem, Luigi Bolondi, Tim F Greten, Peter R Galle, Jean-François Seitz, Ivan Borbath, Dieter Häussinger, Tom Giannaris, Minghua Shan, Marius Moscovici, Dimitris Voliotis, Jordi Bruix, None, Sorafenib in Advanced Hepatocellular Carcinoma The New England Journal of Medicine. ,vol. 359, pp. 378- 390 ,(2008) , 10.1056/NEJMOA0708857
C MATTEONI, Z YOUNOSSI, T GRAMLICH, N BOPARAI, Y LIU, A MCCULLOUGH, Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. ,vol. 116, pp. 1413- 1419 ,(1999) , 10.1016/S0016-5085(99)70506-8
Henrik Møller, Anders Mellemgaard, Knud Lindvig, Jørgen H. Olsen, Obesity and cancer risk: a danish record-linkage study European Journal of Cancer. ,vol. 30, pp. 344- 350 ,(1994) , 10.1016/0959-8049(94)90254-2
Ian R. Wanless, , Terminology of nodular hepatocellular lesions Hepatology. ,vol. 22, pp. 983- 993 ,(1995) , 10.1002/HEP.1840220341
Hashem B. El-serag, Thomas Tran, James E. Everhart, Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma Gastroenterology. ,vol. 126, pp. 460- 468 ,(2004) , 10.1053/J.GASTRO.2003.10.065
Ann-Lii Cheng, Yoon-Koo Kang, Zhendong Chen, Chao-Jung Tsao, Shukui Qin, Jun Suk Kim, Rongcheng Luo, Jifeng Feng, Shenglong Ye, Tsai-Sheng Yang, Jianming Xu, Yan Sun, Houjie Liang, Jiwei Liu, Jiejun Wang, Won Young Tak, Hongming Pan, Karin Burock, Jessie Zou, Dimitris Voliotis, Zhongzhen Guan, None, Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncology. ,vol. 10, pp. 25- 34 ,(2009) , 10.1016/S1470-2045(08)70285-7
Helena Nordenstedt, Donna L. White, Hashem B. El-Serag, The changing pattern of epidemiology in hepatocellular carcinoma. Digestive and Liver Disease. ,vol. 42, ,(2010) , 10.1016/S1590-8658(10)60507-5
J. Ferlay, D.M. Parkin, E. Steliarova-Foucher, Estimates of cancer incidence and mortality in Europe in 2008. European Journal of Cancer. ,vol. 46, pp. 765- 781 ,(2010) , 10.1016/J.EJCA.2009.12.014